Vimarsana
Biggest News Aggregation in the World

Page 3 - Positive Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Positive Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Positive Phase Today - Breaking & Trending Today

Precigen Reports First Quarter 2023 Financial Results and Business Updates - Vimarsana News

Precigen Reports First Quarter 2023 Financial Results and Business Updates

– Positive Phase 1 clinical data presented for PRGN-2012 AdenoVerse™ immunotherapy in RRP demonstrated favorable safety profile and significant reduction in...

AISA Pharma Announces Upcoming Profervia® Data Presentations at AAN and EULAR - Vimarsana News

AISA Pharma Announces Upcoming Profervia® Data Presentations at AAN and EULAR

/PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,...

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases an - Vimarsana News

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases an

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology·        Positive Phase 1 clinical results published in 'The Journal of Immunology’ (online)· &...

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology - Vimarsana News

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology

Positive Phase 1 clinical results published in 'The Journal of Immunology' (online) Two ongoing Phase 2 clinical trials in Ulcerative Colitis and primary Sjögren's Syndrome Positive

Idorsia announces financial results for the first nine - Vimarsana News

Idorsia announces financial results for the first nine

Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland – October 25, 2022Idorsia Ltd (SIX: IDIA) today announced its financial results for the...